TiroSEEN

Área de conocimiento Tiroides de la Sociedad Española de Endocrinología y Nutrición

#EmbajadorSEEN

[American Thyroid Association @AmThyroidAssn]

🦋 June is Differentiated Thyroid Cancer (DTC) Awareness Month. Did you know the ATA® offers #thyroid brochures for patients, medical professionals & general public? Share with your patients and colleagues: https://t.co/z3K6jq38gc
#DTC @thyroidjournal @clinicalthyroid

[Sociedad SEEN @sociedadSEEN]

18F-DOPA-PET/CT role in medullary thyroid cancer patients with biochemical incomplete response 
* La PET/TC con 18F-DOPA demuestra una buena precisión diagnóstica para identificar la enfermedad estructural en pacientes con #CMT con recidiva bioquímica, especialmente cuando se observan lesiones indeterminadas en la ecografía y la TC cervicales
https://t.co/i7tNOQOJxi
@TiroSEEN

[Sociedad SEEN @sociedadSEEN]

Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer
* La terapia neoadyuvante facilitó la resección R0 del carcinoma diferenciado de tiroides localmente avanzado. 
*Lenvatinib indujo remodelación vascular e infiltración inmune, a diferencia de la fibrosis observada principalmente con dabrafenib/trametinib. 
https://t.co/gWF88bQHoM
@TiroSEEN

[European Thyroid Journal @Eur_Thyroid_J]

Should the UK adapt its newborn screening to detect central congenital hypothyroidism (CeCHT)?

Catherine Peters et al. retrospectively evaluated 118 individuals with CeCHT, examining clinical characteristics, time to diagnosis & diagnostic pathways.

🔗 https://t.co/f6s1F1yBpU

[Thyroid Journal @thyroidjournal]

What links BRAFV600E and TERT in aggressive thyroid cancer? A team from @UofT identified DDX21 as a key mediator—driven by MAPK signaling-which partners with TERT to boost rRNA transcription and tumor growth, pointing to a new therapeutic target.
https://t.co/KGz9AO5DrU

[Thyroid Journal @thyroidjournal]

Can 3D tools improve margin assessment in invasive thyroid cancer surgery? A team @IcahnMountSinai introduces MarginView3D, enabling real-time surgeon–pathologist collaboration—helping achieve precise resections in advanced disease.
https://t.co/aOVU31zxbB
@AmThyroidAssn

[Gonzalo Díaz Soto @GonzaloDiazSoto]

A decade of hard work to achieve the first prospective de-escalation study is finally out!
Huge congratulations to the whole team, and especially to @pablofdzvelasco

https://t.co/8JoLgdeq6t

@TiroSEEN @sociedadSEEN @AmThyroidAssn @ETA_Thyroid

[European Thyroid Journal @Eur_Thyroid_J]

🌍 Today is World Thyroid Day

#WorldThyroidDay is an opportunity to recognise the global thyroid community & reaffirm our commitment to those living with thyroid conditions. This year’s focus is on nutrition and its role in supporting thyroid health.

🔗 https://t.co/UBe6fDCgeC

[Sociedad SEEN @sociedadSEEN]

📌 #DiaMundialDelTiroides 

Los nódulos tiroideos son muy frecuentes: más de la mitad de los adultos tiene alguno, pero solo entre el 3% y el 5% son malignos.

Hoy, gracias a las técnicas de imagen y a herramientas como TIRADS, podemos identificar mejor qué casos requieren intervención… y evitar cirugías innecesarias.

🧑‍⚕️Dres. Carles Zafón y Manuel Gargallo de @TiroSEEN 

🔎 Diagnosticar a tiempo y hacer un buen seguimiento es clave en el manejo de la patología tiroidea.

📲 Más información: https://t.co/2S9EJeMv3P

#Endocrinologia #Tiroides #SEEN

[Thyroid Journal @thyroidjournal]

Why is TPO expression reduced in thyroid cancer? A new @ThyroidJournal study shows DNA hypermethylation silences TPO via MBD2 recruitment;TPO methylation assays may accurately distinguish malignant from benign nodules-offering a promising diagnostic tool
https://t.co/cwL1Wnod1j

[Sociedad SEEN @sociedadSEEN]

🆕 #TiroSEEN2026

Arranca la XI Reunión de @TiroSEEN.
Una jornada centrada en avances en patología tiroidea y yodación, con expertos de referencia.

@AscendisPharma @merck_es @Amgen @ESTEVE_ESP

#Endocrinología #Tiroides #SEEN

[Sociedad SEEN @sociedadSEEN]

🔴 En directo | #TiroSEEN2026

Seguimos con el bloque sobre avances en patología benigna y yodación moderado por Emma Anda (@Emma73356210)
✔ Oftalmopatía tiroidea - Dra. Rosa Casañ @RosaCasan
✔ Disfunción tiroidea y gestación- Dra. Berta Soldevila
✔ Resistencia a levotiroxina - Dr. José Carlos Moreno 
✔ “Fake news” en tiroides - Dr. Javier Bodoque y Dr. José Vicente Gil

#SEEN #Tiroides @TiroSEEN

[Thyroid Journal @thyroidjournal]

Does levothyroxine treatment raise cardiovascular risk in women with hypothyroidism? In the SWAN cohort, @mettleson and coauthors report no increased risk of MI, stroke, HF, or revascularization in LT4-treated women vs those without thyroid disease. https://t.co/ctnmULX8kj

[Thyroid Journal @thyroidjournal]

What is the long-term thyroid impact of Rx for children with high-risk neuroblastoma? A new study found >50% of survivors developed thyroid toxicity-esp after molecular radiotherapy, immunotherapy, or busulfan, underscoring need for lifelong follow-up.
https://t.co/waM3KSiTRn

[Thyroid Journal @thyroidjournal]

Can rehab exercises help swallowing after thyroidectomy? A @ThyroidJournal RCT shows a 3-month program of neck, swallowing & voice exercises improved swallowing-related QoL at 1 and 6 months vs usual care—safe, with only mild early pain increase.
https://t.co/cxT2Edk71J

[TiroSEEN @TiroSEEN]

Novedades en tratamiento con Radioyodo en CDT. Dr Juan Ignacio Cuesta.

[TiroSEEN @TiroSEEN]

Guías ATA. Tratamiento inicial y factores de riesgo. ¿Desescalada y alta a qué pacientes?. Dra Augusta Guillen.

[TiroSEEN @TiroSEEN]

¿Es útil la IA en la consulta de un Endocrinólogo experto?. Debate PRO-CON con los Dres Jordi Reverter y Gonzalo Díaz Soto.